Midazolam
Injection · trading as Midazolam In Sodium Chloride
Current
FDA shortage record
- Substance
- Midazolam
- Brand name
- Midazolam In Sodium Chloride
- Manufacturer
- WG Critical Care, LLC.
- Dosage form
- Injection
- Presentation
- Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)
- Route(s)
- INTRAVENOUS
- Therapeutic category
- Anesthesia, Neurology
- Package NDC
44567-611-10- Initially posted
- 04/02/2020
- Current FDA status
- Current
Reason and context
Please check wholesalers and distributors for inventory.
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 888-493-0861.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
f051776f-94c5-4e34-80ed-f45b9c36881e). - FDA UNII identifier:
R60L0SM5BC. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.